Predictors of persistent post transplant hyperparathyroidism (HPTx)

Luiz Roberto Sousa Ulisses,Marcos Vinícius De Sousa,Marilda Mazzali,Gabriel Giollo Rivelli,Leonardo Figueiredo Camargo,Carla Feitosa Do Vale

doi:10.53855/bjt.v18i1.121

Luiz Roberto Sousa Ulisses, Marcos Vinícius De Sousa + Show 4 more

Open Access

https://doi.org/10.53855/bjt.v18i1.121

Copy DOI

Abstract

Post transplant persistent Hyperparathyroidism (HPTx) increases the risk for transplant complications. Purpose: to identify risk factors for HPTx in the first post transplant year. Methods: Retrospective analysis of medical records from renal transplant recipients from July/2008 to December/2010. Inclusion criteria: serum PTH ≥500 pg/ml at transplant and normal 1-year graft function (serum creatinine ≤ 2mg/dL). From a group of 224 renal transplants, 69 (30%) fulfilled the inclusion criteria, and they were divided in 2 groups, according to the serum PTH after 1 year of transplant: control, 1-year P TH<150 p g/ml ( n=32) a nd P ersistent H yperparathyroidism, H PTx, 1 -year P TH ≥ 1 50 p g/ml ( n= 3 7). Data analyzed: serum calcium (Ca), phosphate (Pi), alkaline phosphatase (AP), PTH and glomerular filtration rate (GFR) at transplant, and 3, 6 and 12 months post transplant. Results: At transplant, the groups were comparable as to age, Pi and PTH. However, the length of the dialysis (78 40 vs. 50 34 months, p<0.05) and Ca (8,9 0.9 vs. 8,5 0,6mg/dL, p<0.05) were higher in the HPTx group. After 3 months post transplant, HPTx group maintained higher PTH levels (365.4 176.2 vs. 166.9 92.2pg/mL, p<0.05), and AP (175 145 vs. 109 52UI, p<0.05), than controls, despite of the comparable Ca, Pi, and GFR. From the 6th post transplant month, the HPTx group persisted with hypercalcemia (10.2 0.7 vs. 9.9 0.5mg/dL, p<0.05) and low phosphate (2.6 0.5 vs. 2.9 0.7, p<0.05) with higher AP and PTH levels than in controls (p<0.05). At the end of the 1 post transplant year, HPTx group persisted with hypercalcemia, despite the recovery of the graft function while in the control group, the GFR recovery was associated with normalization of the bone mineral metabolism parameters. Conclusion: HPTx was associated with longer pre transplant dialysis therapy and higher Ca at transplant. Higher PTH and AP post transplant levels at the 3rd month were associated with persistent hyperparathyroidism, as well as persistent hypercalcemia and low phosphate, despite of the GFR recovery.

Highlights

Chronic renal disease promotes major changes in the bone mineral metabolism
The reduction in the rate of glomerular filtration is associated with a lower synthesis of the active vitamin D that reduces the intestinal calcium absorption, leading to hypocalcemia and stimulation of the parathyroid gland to synthetize PTH in order to restore calcium levels
We observed a trend to hypercalcemia in the HPTx group (9.9 ± 1.1 vs. 9.5 ± 0.6 mg/dL, p=0.06), which was marked after six (10.2 ± 0.7 mg/dL, p < 0.05) and 12 post transplant months (10.5 ± 0.8 vs. 10 ± 0.7 mg/dL, p

Summary

Introduction

The reduction in the rate of glomerular filtration is associated with a lower synthesis of the active vitamin D that reduces the intestinal calcium absorption, leading to hypocalcemia and stimulation of the parathyroid gland to synthetize PTH in order to restore calcium levels. PTH increases the bone reabsorption, increasing the serum calcium. Persistent stimuli of the PTH synthesis results in nodular or diffuse parathyroid hyperplasia, leading to a down regulation of Ca and to vitamin D receptors, and hypercalcemia can be frequent. It occurs an increase in the FGF-23 levels with increasing serum phosphate and calcium/phosphate product.[1,2,3].

Objectives

Results

Conclusion